Nicole MAIRON

En résumé

Entreprises

• Roche - Safety Science Leader, Global, MabThera/Rituxan, Auto-Immune diseases

  Boulogne-Billancourt 2012 - maintenant

• Merck-Serono - Geneva - Switzerland - Sr Medical Director Endocrinology Clinical Development and Medical Affairs

  2010 - 2012 European approval of a new liquid formulation for SAIZEN (growth hormone)

• Wyeth Pharmaceuticals - Paris - France - Head of Women's Health and Bone Repair for Europe

  2008 - 2010 European approval for Bazedoxifene (Conbriza), treatment for postmenopausal osteoporosis
  
  Wyeth from 1998 to 2003 and 2008 to 2010

• Hoffmann La Roche - Basel - Switzerland - Clinical Science Leader

  2003 - 2008 Approval worldwide of Boniva-Bonviva monthly tablets for Osteoporosis
  First in Man of a new chemical entity for chronic pain and overactive bladder
  Implementation of phase II with Ocrelizumab in RRMS

Formations

Réseau

• Alexia RICHARD

• Christine SALVANT

• Claire LEURENT

• Daniel GISSINGER

• Edith VAYSSE

• Eulalie FERREIRA

• Sophie CHANIER

• Stephanie WAYMEL

• Sylvie JOUVE

• Yves BRAULT